|
1
|
Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology.
|
J Control Release
|
2005
|
2.17
|
|
2
|
Localized delivery of growth factors for bone repair.
|
Eur J Pharm Biopharm
|
2004
|
1.30
|
|
3
|
Nerve conduits and growth factor delivery in peripheral nerve repair.
|
J Peripher Nerv Syst
|
2007
|
1.29
|
|
4
|
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses.
|
Vaccine
|
2008
|
1.26
|
|
5
|
Formulation aspects of biodegradable polymeric microspheres for antigen delivery.
|
Adv Drug Deliv Rev
|
2005
|
1.22
|
|
6
|
Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
|
J Control Release
|
2010
|
1.20
|
|
7
|
Silk fibroin matrices for the controlled release of nerve growth factor (NGF).
|
Biomaterials
|
2007
|
1.17
|
|
8
|
Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro.
|
Vaccine
|
2003
|
1.14
|
|
9
|
Localized insulin-like growth factor I delivery to enhance new bone formation.
|
Bone
|
2003
|
1.12
|
|
10
|
Particulate vaccines: on the quest for optimal delivery and immune response.
|
Drug Discov Today
|
2011
|
1.10
|
|
11
|
Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration.
|
J Peripher Nerv Syst
|
2010
|
1.07
|
|
12
|
Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro.
|
Neurosci Res
|
2009
|
1.05
|
|
13
|
Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells.
|
Vaccine
|
2005
|
1.05
|
|
14
|
In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres.
|
Eur J Pharm Sci
|
2002
|
1.01
|
|
15
|
Growth factor delivery systems and repair strategies for damaged peripheral nerves.
|
J Control Release
|
2011
|
0.99
|
|
16
|
Collagen nerve conduits releasing the neurotrophic factors GDNF and NGF.
|
J Control Release
|
2009
|
0.98
|
|
17
|
Lympho-geographical concepts in vaccine delivery.
|
J Control Release
|
2010
|
0.97
|
|
18
|
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response.
|
J Drug Target
|
2009
|
0.97
|
|
19
|
Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice.
|
J Antimicrob Chemother
|
2005
|
0.92
|
|
20
|
Delivery of tumor antigens to dendritic cells using biodegradable microspheres.
|
Methods Mol Med
|
2005
|
0.89
|
|
21
|
Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability.
|
Int J Pharm
|
2010
|
0.89
|
|
22
|
Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes.
|
J Antimicrob Chemother
|
2004
|
0.88
|
|
23
|
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy.
|
J Immunol Methods
|
2004
|
0.88
|
|
24
|
Effect of controlled co-delivery of synergistic neurotrophic factors on early nerve regeneration in rats.
|
Biomaterials
|
2010
|
0.87
|
|
25
|
Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis.
|
J Control Release
|
2008
|
0.86
|
|
26
|
Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits.
|
Eur J Pharm Biopharm
|
2008
|
0.86
|
|
27
|
Ultrasonic atomisation into reduced pressure atmosphere--envisaging aseptic spray-drying for microencapsulation.
|
J Control Release
|
2004
|
0.86
|
|
28
|
One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands.
|
J Control Release
|
2005
|
0.85
|
|
29
|
The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles.
|
Biomaterials
|
2006
|
0.85
|
|
30
|
Continuous contact- and contamination-free ultrasonic emulsification-a useful tool for pharmaceutical development and production.
|
Ultrason Sonochem
|
2004
|
0.85
|
|
31
|
Variations in glial cell line-derived neurotrophic factor release from biodegradable nerve conduits modify the rate of functional motor recovery after rat primary nerve repairs.
|
Eur J Neurosci
|
2007
|
0.84
|
|
32
|
In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation.
|
Vaccine
|
2004
|
0.83
|
|
33
|
A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles.
|
Pharm Res
|
2007
|
0.82
|
|
34
|
Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres.
|
J Control Release
|
2004
|
0.82
|
|
35
|
Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice.
|
J Control Release
|
2005
|
0.82
|
|
36
|
Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration.
|
Pharm Res
|
2005
|
0.81
|
|
37
|
Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
|
Eur J Pharm Biopharm
|
2011
|
0.81
|
|
38
|
Development of synthetic biodegradable microparticulate vaccines: a roller coaster story.
|
Expert Rev Vaccines
|
2007
|
0.81
|
|
39
|
Hydrogel nerve conduits produced from alginate/chitosan complexes.
|
J Biomed Mater Res A
|
2007
|
0.80
|
|
40
|
On technological and immunological benefits of multivalent single-injection microsphere vaccines.
|
Pharm Res
|
2002
|
0.80
|
|
41
|
An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria.
|
J Pharm Sci
|
2003
|
0.80
|
|
42
|
Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvant.
|
Int J Cancer
|
2011
|
0.79
|
|
43
|
Formulation and drying of miconazole and itraconazole nanosuspensions.
|
Int J Pharm
|
2013
|
0.79
|
|
44
|
Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions.
|
J Control Release
|
2004
|
0.78
|
|
45
|
Impact of IGF-I release kinetics on bone healing: a preliminary study in sheep.
|
Eur J Pharm Biopharm
|
2013
|
0.77
|
|
46
|
Nerve conduit scaffolds for discrete delivery of two neurotrophic factors.
|
Eur J Pharm Biopharm
|
2013
|
0.77
|
|
47
|
Polyelectrolyte LbL microcapsules versus PLGA microparticles for immunization with a protein antigen.
|
J Control Release
|
2011
|
0.76
|
|
48
|
Kinetics of solvent extraction/evaporation process for PLGA microparticle fabrication.
|
Int J Pharm
|
2008
|
0.76
|
|
49
|
Effect of oil-in-water emulsions on 5-aminolevulinic acid uptake and metabolism to PpIX in cultured MCF-7 cells.
|
Pharm Res
|
2004
|
0.76
|
|
50
|
Flow-through ultrasonic emulsification combined with static micromixing for aseptic production of microspheres by solvent extraction.
|
Eur J Pharm Biopharm
|
2005
|
0.76
|
|
51
|
Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives.
|
J Pharm Pharmacol
|
2004
|
0.75
|
|
52
|
Simultaneous quantification of polymeric and surface active stabilizers of nanosuspensions by using near-infrared spectroscopy.
|
Drug Dev Ind Pharm
|
2012
|
0.75
|
|
53
|
Foreword - In honor of Prof. em. Dr. Hans Peter Merkle on the occasion of his 70th birthday.
|
Eur J Pharm Biopharm
|
2013
|
0.75
|
|
54
|
Development of a novel casein-protamine based microparticles for early feeding of fish larvae: in vitro evaluation.
|
J Microencapsul
|
2007
|
0.75
|